Soft Tissue Width and Abutment Height Influence Peri-implant Bone Resorption

NCT ID: NCT03229005

Last Updated: 2019-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-15

Study Completion Date

2019-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical and radiographic study will be to determine what influence on marginal bone loss has the thickness of soft tissues and the height of the prosthetic abutment and eventually determine which of the two factors is the most important.This research was designed as a multicentre cohort study. Two clinical centers will treat patients through the placement of a single dental implant. The implants will be prosthetically loaded about 4 months after placement and periapical radiographs will be acquired at each time-point.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this clinical and radiographic study will be to determine what influence on marginal bone loss has the thickness of soft tissues and the height of the prosthetic abutment and eventually determine which of the two factors is the most important.This research was designed as a multicentre cohort observational study. Two clinical centers will treat patients through the placement of a single dental implant. The implants will be prosthetically loaded about 4 months after placement and periapical radiographs will be acquired at each time-point.

All patients will receive antibiotic prophylaxis with 2 g of amoxicillin one hour before surgery. With the help of a dissector, a full thickness vestibular flap will be carefully arranged and the vertical thickness of soft tissues will be measured with a probe marked every 1.0 mm. If the vertical thickness of the soft tissue is 2 mm or less, the tissue will be considered thin. If the thickness of the mucosa is greater than 2 mm, it will be considered thick. After the measurement, the lingual flap will be elevated at full thickness, and the site for site placement will be prepared. The implant bed will be at least 1.5 mm from the adjacent tooth or teeth, and must be surrounded by at least 1 mm bone in both buccal and lingual directions. A 3,75 mm diameter and internal hexagonal connection implant will be placed at the level of the bone crest according to the manufacturer's recommendations. Operators will be free to choose the most suitable system length (8, 10, 11.5 mm). All implants will be submerged according to a traditional two-stage protocol. After insertion, the flaps will be sutured without tension with interrupted sutures. Patients of both groups will be instructed to disinfect the site by rinsing twice daily for one week for 1 minute with 0.12% chlorhexidine. After 4 months of healing, the treated area will be reopened for connecting the healing abutments with a crestal incision that will retain the keratinized tissue; The same soft tissue measurements will be repeated as confirmation of what was done during the first surgical implant insertion phase. The implants will be considered osteointegrated successfully if they are clinically intact unless they show obvious radiotransparency and patients will not report any pain. After this step, it will be possible to divide the patients into 2 groups according to the thickness of the soft tissue: a group with thick tissue (more than 2.0 mm); Slim tissue group (less than 2.0 mm). The prosthetic framework will be bonded directly to prefabricated titanium abutment (1 or 3 mm). This will result in the formation of 4 different subgroups: a group with thick tissue and high prosthetic abutment; A group with thick tissue and low prosthetic stump; a group with thin tissue and high prosthetic abutment; a group with thin tissue and low prosthetic abutment.

All the implants will be rehabilitated by the dentist with screwed restorations. After prosthetic treatment, patients will receive oral hygiene instructions and will be monitored through calls to ensure periodontal health throughout the study period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alveolar Bone Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A1 thick-high

group with thick tissue and high prosthetic abutment tissue measurement implant insertion operculectomy prosthetic rehabilitation

Group Type ACTIVE_COMPARATOR

implant insertion

Intervention Type PROCEDURE

during surgery soft tissues will be measured

operculectomy

Intervention Type PROCEDURE

during second surgery soft tissues will be measured again

prosthetic rehabilitation

Intervention Type PROCEDURE

after three months implants will be loaded with screw retained crown

A2 thick-low

group with thick tissue and low prosthetic abutment tissue measurement implant insertion operculectomy prosthetic rehabilitation

Group Type EXPERIMENTAL

implant insertion

Intervention Type PROCEDURE

during surgery soft tissues will be measured

operculectomy

Intervention Type PROCEDURE

during second surgery soft tissues will be measured again

prosthetic rehabilitation

Intervention Type PROCEDURE

after three months implants will be loaded with screw retained crown

B1 thin-high

group with thin tissue and high prosthetic abutment tissue measurement implant insertion operculectomy prosthetic rehabilitation

Group Type ACTIVE_COMPARATOR

implant insertion

Intervention Type PROCEDURE

during surgery soft tissues will be measured

operculectomy

Intervention Type PROCEDURE

during second surgery soft tissues will be measured again

prosthetic rehabilitation

Intervention Type PROCEDURE

after three months implants will be loaded with screw retained crown

B2 thin-low

group with thin tissue and low prosthetic abutment tissue measurement implant insertion operculectomy prosthetic rehabilitation

Group Type EXPERIMENTAL

implant insertion

Intervention Type PROCEDURE

during surgery soft tissues will be measured

operculectomy

Intervention Type PROCEDURE

during second surgery soft tissues will be measured again

prosthetic rehabilitation

Intervention Type PROCEDURE

after three months implants will be loaded with screw retained crown

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

implant insertion

during surgery soft tissues will be measured

Intervention Type PROCEDURE

operculectomy

during second surgery soft tissues will be measured again

Intervention Type PROCEDURE

prosthetic rehabilitation

after three months implants will be loaded with screw retained crown

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age\>18 years;
* good general health;
* non smokers;
* absence of systemic diseases affecting bone metabolism and wound healing; - no regular medication consumption for at least 3 months prior to treatment; - patient willing and fully capable to comply with the study protocol;
* written informed consent given.


* presence of keratinized mucosa with a minimum bucco-lingual width of 3 mm; - bone crest with at least 6 mm of width and 9 mm of height above the mandibular canal, without concomitant or previous bone augmentation procedures;
* presence of the opposing dentition.

Exclusion Criteria

* history of head or neck radiation therapy;
* uncontrolled diabetes (HBA1c \>7.5%);
* active infections;
* immunocompromised patients (HIV infection or chemotherapy within the past 5 years);
* present or past treatment with intravenous bisphosphonates;
* patient pregnancy or lactating at any time during the study;
* poor oral hygiene and motivation;
* untreated periodontal disease;
* psychological or psychiatric problems;
* alcohol or drugs abuse;
* participating in other studies, if the present protocol could not be properly followed;
* lack of implant primary stability.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

International Piezosurgery Academy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mr. Claudio Stacchi, DDS, MSc

President of the Academy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claudio Stacchi, Dr.

Role: PRINCIPAL_INVESTIGATOR

Piezosurgery Academy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Piezosurgery Academy

Parma, PR, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Galindo-Moreno P, Leon-Cano A, Monje A, Ortega-Oller I, O'Valle F, Catena A. Abutment height influences the effect of platform switching on peri-implant marginal bone loss. Clin Oral Implants Res. 2016 Feb;27(2):167-73. doi: 10.1111/clr.12554. Epub 2015 Feb 11.

Reference Type BACKGROUND
PMID: 25678247 (View on PubMed)

Linkevicius T, Apse P, Grybauskas S, Puisys A. Influence of thin mucosal tissues on crestal bone stability around implants with platform switching: a 1-year pilot study. J Oral Maxillofac Surg. 2010 Sep;68(9):2272-7. doi: 10.1016/j.joms.2009.08.018.

Reference Type BACKGROUND
PMID: 20605308 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

i-RES

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.